2024
DOI: 10.1016/j.jconrel.2024.03.040
|View full text |Cite
|
Sign up to set email alerts
|

An adaptive drug-releasing contact lens for personalized treatment of ocular infections and injuries

Rong Sun,
Jie Zhang,
Xi Chen
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Targeted and on-demand drug delivery is a cornerstone of SCL development. Sun et al ( 2024) developed an innovative contact lens that releases levofloxacin and diclofenac in response to elevated levels of reactive oxygen species (ROS) present at the site of ocular inflammation [71]. This model could be further developed not only to administer therapy, but also to monitor disease progression and treatment management.…”
Section: Dry Eyesmentioning
confidence: 99%
“…Targeted and on-demand drug delivery is a cornerstone of SCL development. Sun et al ( 2024) developed an innovative contact lens that releases levofloxacin and diclofenac in response to elevated levels of reactive oxygen species (ROS) present at the site of ocular inflammation [71]. This model could be further developed not only to administer therapy, but also to monitor disease progression and treatment management.…”
Section: Dry Eyesmentioning
confidence: 99%
“…Clinical manifestations may include widespread punctate defects or erosions on the corneal surface, along with continuous detachment and damage to the epithelium ( 224 ). Additionally, varying levels of inflammation affecting the ocular surface may be present ( 225 ). In severe instances, such injuries can lead to pathological alterations in the corneal stroma, potentially impacting visual acuity ( 226 ).…”
Section: Ferroptosis and Ophthalmic Disordersmentioning
confidence: 99%